semaglutide anti aging Low doses of popular weight-loss drugs can reverse ageing, scientists say Weight-loss drugs 'slow down the

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Ozempic, Rybelsus) and chronic weight management (Wegovy)

10.1016/j.celrep.2018.05.009 Cell Rep

n=338) demonstrated dose-dependent weight loss over 48 weeks: The 24.2% weight loss at the 12 mg dose was the largest mean weight loss reported for any anti-obesity medication at the time of publication

Contact your GP, diabetes specialist nurse, or NHS 111 if: Headaches are persistent, worsening, or significantly impacting daily activities despite simple management measures You experience frequent hypoglycaemic episodes (blood glucose below 4 mmol/L) [31] [32] You have signs of dehydration such as reduced urine output, excessive thirst, or dizziness when standing Side effects are affecting medication adherence or quality of life You develop new or unusual symptoms that concern you Headaches follow a different pattern from any pre-existing headache disorder Healthcare professionals can assess whether headaches are likely related to GLP-1 therapy or require investigation for alternative causes

Avoidance of Alcohol and Smoking: Both substances can interfere with the effectiveness of glutathione and overall skin health